Methods for treating asthma using optically pure (-)-zileuton
US5629337A · kind A · utility
6Cited by
1References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 5, 1995 |
| Grant date | May 13, 1997 |
| Priority date | — |
| Expiry date | Jan 5, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are disclosed utilizing optically pure (-)-zileuton for the treatment of asthma in humans while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of zileuton.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.